Skip to main content

Advertisement

Log in

Pharmacological Management of Central Post-Stroke Pain: A Practical Guide

  • Therapy in Practice
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Pain is one of the most troublesome sequelae of stroke. Some of this post-stroke pain is caused by the brain lesion itself; this is called central post-stroke pain (CPSP). Although the prevalence of CPSP is low (1–8 %), persistent, often treatment-resistant, painful sensations are a major problem for stroke patients. The pathogenesis of CPSP remains unknown, but suggested underlying causes include hyperexcitation in the damaged sensory pathways, damage to the central inhibitory pathways, or a combination of the two. For pharmacological treatment, amitriptyline, an adrenergic antidepressant, is currently the first-line drug for CPSP. However, its effect is frequently incomplete and a high dose is commonly not tolerated in stroke patients. Lamotrigine, an antiepileptic, was also found to be effective in a controlled trial and can be used as an alternative or additive therapy. GABAergic drugs with potential calcium channel-blocking effects, such as gabapentin or pregabalin, have recently emerged as a potentially useful therapy. These drugs are effective in various neuropathic pain syndromes, but their effect on CPSP remains to be proven. Pregabalin may improve pain-related anxiety and sleep disturbances. Fluvoxamine and mexiletine may be used adjunctively in some patients. Non-pharmacological treatments such as motor cortex stimulation or deep brain stimulation are used in some centers, but are not proven to be effective. Further well designed clinical trials as well as basic research should be performed to improve our understanding of the pathophysiology of CPSP and to develop better treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G. Medical complications after stroke: a multicenter study. Stroke. 2000;31:1223–9.

    CAS  PubMed  Google Scholar 

  2. Gamble GE, Barberan E, Laasch HU, Bowsher D, Tyrrell PJ, Jones AK. Poststroke shoulder pain: a prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke. Eur J Pain. 2002;6:467–74.

    PubMed  Google Scholar 

  3. Widar M, Samuelsson L, Karlsson-Tivenius S, Ahlstrom G. Long-term pain conditions after a stroke. J Rehabil Med. 2002;34:165–70.

    PubMed  Google Scholar 

  4. Ratnasabapathy Y, Broad J, Baskett J, Pledger M, Marshall J, Bonita R. Shoulder pain in people with a stroke: a population-based study. Clin Rehabil. 2003;17:304–11.

    PubMed  Google Scholar 

  5. McLean DE. Medical complications experienced by a cohort of stroke survivors during inpatient, tertiary-level stroke rehabilitation. Arch Phys Med Rehabil. 2004;85:466–9.

    PubMed  Google Scholar 

  6. Widar M, Ek AC, Ahlstrom G. Coping with long-term pain after a stroke. J Pain Symptom Manag. 2004;27:215–25.

    Google Scholar 

  7. Jonsson AC, Lindgren I, Hallstrom B, Norrving B, Lindgren A. Prevalence and intensity of pain after stroke: a population based study focusing on patients’ perspectives. J Neurol Neurosurg Psychiatry. 2006;77:590–5.

    PubMed Central  PubMed  Google Scholar 

  8. Sackley C, Brittle N, Patel S, Ellins J, Scott M, Wright C, Dewey ME. The prevalence of joint contractures, pressure sores, painful shoulder, other pain, falls, and depression in the year after a severely disabling stroke. Stroke. 2008;39:3329–34.

    PubMed  Google Scholar 

  9. Greiff F. Zure localisation der hemichorea. Arch Psychiatr. 1883;14:598–624.

    Google Scholar 

  10. Edinger L. Giebt es central entstehende schmerzen ? Dtsch Z Nervenheilkd. 1891;1:262–82.

    Google Scholar 

  11. Déjerine J, Roussy G. Le syndrome thalamique. Rev Neurology. 1906;14:521–32.

    Google Scholar 

  12. Leijon G, Boivie J, Johansson I. Central post-stroke pain—neurological symptoms and pain characteristics. Pain. 1989;36:13–25.

    CAS  PubMed  Google Scholar 

  13. Tasker RR, de Carvalho G, Dostrovsky JO. The history of central pain syndromes, with observations concerning pathophysiology and treatment. New York: Raven Press; 1991.

    Google Scholar 

  14. Schmahmann JD, Leifer D. Parietal pseudothalamic pain syndrome. Clinical features and anatomic correlates. Arch Neurol. 1992;49:1032–7.

    CAS  PubMed  Google Scholar 

  15. Vestergaard K, Nielsen J, Andersen G, Ingeman-Nielsen M, Arendt-Nielsen L, Jensen TS. Sensory abnormalities in consecutive, unselected patients with central post-stroke pain. Pain. 1995;61:177–86.

    CAS  PubMed  Google Scholar 

  16. Schott GD. From thalamic syndrome to central poststroke pain. J Neurol Neurosurg Psychiatry. 1996;61:560–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  17. Jensen TS, Lenz FA. Central post-stroke pain: a challenge for the scientist and the clinician. Pain. 1995;61:161–4.

    CAS  PubMed  Google Scholar 

  18. Pagni C. Central pain and painful paresthesia. Prog Neurol Surg. 1976;8:132–257.

    Google Scholar 

  19. Kim JS, Choi-Kwon S. Sensory sequelae of medullary infarction: differences between lateral and medial medullary syndrome. Stroke. 1999;30:2697–703.

    CAS  PubMed  Google Scholar 

  20. Kim JS. Central post-stroke pain or paresthesia in lenticulocapsular hemorrhages. Neurology. 2003;61:679–82.

    PubMed  Google Scholar 

  21. Bowsher D. Sensory consequences of stroke. Lancet. 1993;341:156.

    CAS  PubMed  Google Scholar 

  22. Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain. 1995;61:187–93.

    CAS  PubMed  Google Scholar 

  23. Henry JL, Lalloo C, Yashpal K. Central poststroke pain: an abstruse outcome. Pain Res Manag. 2008;13:41–9.

    PubMed Central  PubMed  Google Scholar 

  24. Bonica J. Introduction: semantic, epidemiologic, and educational issues. New York: Raven Press; 1991.

    Google Scholar 

  25. Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22:252–60.

    CAS  PubMed  Google Scholar 

  26. Kumar B, Kalita J, Kumar G, Misra UK. Central poststroke pain: a review of pathophysiology and treatment. Anesth Analg. 2009;108:1645–57.

    PubMed  Google Scholar 

  27. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8:857–68.

    PubMed  Google Scholar 

  28. Siniscalchi A, Gallelli L, De Sarro G, Malferrari G, Santangelo E. Antiepileptic drugs for central post-stroke pain management. Pharmacol Res. 2012;65:171–5.

    CAS  PubMed  Google Scholar 

  29. Misra UK, Kalita J, Kumar B. A study of clinical, magnetic resonance imaging, and somatosensory-evoked potential in central post-stroke pain. J Pain. 2008;9:1116–22.

    PubMed  Google Scholar 

  30. Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry. 1996;61:62–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Shintani S. Clinical-radiologic correlations in pure sensory stroke. Neurology. 1998;51:297–302.

    CAS  PubMed  Google Scholar 

  32. Bowsher D, Leijon G, Thuomas KA. Central poststroke pain: correlation of MRI with clinical pain characteristics and sensory abnormalities. Neurology. 1998;51:1352–8.

    CAS  PubMed  Google Scholar 

  33. Bogousslavsky J, Regli F, Uske A. Thalamic infarcts: clinical syndromes, etiology, and prognosis. Neurology. 1988;38:837–48.

    CAS  PubMed  Google Scholar 

  34. Kim JS. Lenticulocapsular hemorrhages presenting as pure sensory stroke. Eur Neurol. 1999;42:128–31.

    CAS  PubMed  Google Scholar 

  35. Kim JS. Patterns of sensory abnormality in cortical stroke: evidence for a dichotomized sensory system. Neurology. 2007;68:174–80.

    PubMed  Google Scholar 

  36. Kim JS, Bae YH. Pure or predominant sensory stroke due to brain stem lesion. Stroke. 1997;28:1761–4.

    CAS  PubMed  Google Scholar 

  37. Kim JS. Pure lateral medullary infarction: clinical-radiological correlation of 130 acute, consecutive patients. Brain. 2003;126:1864–72.

    PubMed  Google Scholar 

  38. MacGowan DJ, Janal MN, Clark WC, Wharton RN, Lazar RM, Sacco RL, Mohr JP. Central poststroke pain and Wallenberg’s lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology. 1997;49:120–5.

    CAS  PubMed  Google Scholar 

  39. Kim JS, Kim HG, Chung CS. Medial medullary syndrome. Report of 18 new patients and a review of the literature. Stroke. 1995;26:1548–52.

    CAS  PubMed  Google Scholar 

  40. Hansson P. Post-stroke pain case study: clinical characteristics, therapeutic options and long-term follow-up. Eur J Neurol. 2004;11(Suppl 1):22–30.

    PubMed  Google Scholar 

  41. Casey K. Pain and central nervous system disease: a summary and overview. New York: Raven Press; 1991.

    Google Scholar 

  42. Kim JS. Aggravation of poststroke sensory symptoms after a second stroke on the opposite side. Eur Neurol. 1999;42:200–4.

    CAS  PubMed  Google Scholar 

  43. Soria ED, Fine EJ. Disappearance of thalamic pain after parietal subcortical stroke. Pain. 1991;44:285–8.

    CAS  PubMed  Google Scholar 

  44. Helmchen C, Lindig M, Petersen D, Tronnier V. Disappearance of central thalamic pain syndrome after contralateral parietal lobe lesion: implications for therapeutic brain stimulation. Pain. 2002;98:325–30.

    CAS  PubMed  Google Scholar 

  45. Talbot JD, Marrett S, Evans AC, Meyer E, Bushnell MC, Duncan GH. Multiple representations of pain in human cerebral cortex. Science. 1991;251:1355–8.

    CAS  PubMed  Google Scholar 

  46. Casey KL, Minoshima S, Berger KL, Koeppe RA, Morrow TJ, Frey KA. Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol. 1994;71:802–7.

    CAS  PubMed  Google Scholar 

  47. Derbyshire SW, Jones AK, Devani P, Friston KJ, Feinmann C, Harris M, Pearce S, Watson JD, Frackowiak RS. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol Neurosurg Psychiatry. 1994;57:1166–72.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Craig AD, Reiman EM, Evans A, Bushnell MC. Functional imaging of an illusion of pain. Nature. 1996;384:258–60.

    CAS  PubMed  Google Scholar 

  49. Derbyshire SW, Jones AK, Gyulai F, Clark S, Townsend D, Firestone LL. Pain processing during three levels of noxious stimulation produces differential patterns of central activity. Pain. 1997;73:431–45.

    CAS  PubMed  Google Scholar 

  50. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 1997;277:968–71.

    CAS  PubMed  Google Scholar 

  51. May A, Kaube H, Buchel C, Eichten C, Rijntjes M, Juptner M, Weiller C, Diener HC. Experimental cranial pain elicited by capsaicin: a pet study. Pain. 1998;74:61–6.

    CAS  PubMed  Google Scholar 

  52. Peyron R, Garcia-Larrea L, Gregoire MC, Convers P, Lavenne F, Veyre L, Froment JC, Mauguiere F, Michel D, Laurent B. Allodynia after lateral-medullary (Wallenberg) infarct. A pet study. Brain. 1998;121(Pt 2):345–56.

    PubMed  Google Scholar 

  53. Schreckenberger M, Siessmeier T, Viertmann A, Landvogt C, Buchholz HG, Rolke R, Treede RD, Bartenstein P, Birklein F. The unpleasantness of tonic pain is encoded by the insular cortex. Neurology. 2005;64:1175–83.

    CAS  PubMed  Google Scholar 

  54. Craig AD, Chen K, Bandy D, Reiman EM. Thermosensory activation of insular cortex. Nat Neurosci. 2000;3:184–90.

    CAS  PubMed  Google Scholar 

  55. Craig A. Mechanisms of thalamic pain. Seattle: IASP Press; 2007.

    Google Scholar 

  56. Head HHG. Sensory disturbances from cerebral lesions. Brain. 1911;34:102–254.

    Google Scholar 

  57. Tasker RR. Identification of pain processing systems by electrical stimulation of the brain. Hum Neurobiol. 1982;1:261–72.

    CAS  PubMed  Google Scholar 

  58. Nathan PWSM. Dysesthe´sie apre`s cordotomie. Med Hyg. 1984;42(42):1788–90.

    Google Scholar 

  59. Leijon G, Boivie J. Central post-stroke pain—a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36:27–36.

    CAS  PubMed  Google Scholar 

  60. Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88:1547–60.

    PubMed  Google Scholar 

  61. Lampl C, Yazdi K, Roper C. Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study. Stroke. 2002;33:3030–2.

    CAS  PubMed  Google Scholar 

  62. Vestergaard KAG, Jensen TS. Treatment of central post-stroke pain with a selective serotonin reuptake inhibitor. Eur J Neurol. 1996;3(Suppl 5):169.

    Google Scholar 

  63. Shimodozono M, Kawahira K, Kamishita T, Ogata A, Tohgo S, Tanaka N. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. Int J Neurosci. 2002;112:1173–81.

    PubMed  Google Scholar 

  64. Cantor FK. Phenytoin treatment of thalamic pain. Br Med J. 1972;4:590.

    CAS  PubMed Central  PubMed  Google Scholar 

  65. Mladinich EK. Diphenylhydantoin in the Wallenberg syndrome. JAMA. 1974;230:1230–2.

    Google Scholar 

  66. Agnew DC, Goldberg VD. A brief trial of phenytoin therapy for thalamic pain. Bull Los Angel Neurol Soc. 1976;41:9–12.

    CAS  Google Scholar 

  67. Canavero S, Bonicalzi V. Lamotrigine control of central pain. Pain. 1996;68:179–81.

    CAS  PubMed  Google Scholar 

  68. Carrieri PB, Provitera VV, Lavorgna L, Bruno R. Response of thalamic pain syndrome to lamotrigine. Eur J Neurol. 1998;5:625–6.

    PubMed  Google Scholar 

  69. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56:184–90.

    CAS  PubMed  Google Scholar 

  70. Breuer B, Pappagallo M, Knotkova H, Guleyupoglu N, Wallenstein S, Portenoy RK. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther. 2007;29:2022–30.

    CAS  PubMed  Google Scholar 

  71. Canavero S, Bonicalzi V, Castellano G. Two in one: the genesis of central pain. Pain. 1996;64:394–5.

    CAS  PubMed  Google Scholar 

  72. Bowsher D. The management of central post-stroke pain. Postgrad Med J. 1995;71:598–604.

    CAS  PubMed Central  PubMed  Google Scholar 

  73. Takahashi Y, Hashimoto K, Tsuji S. Successful use of zonisamide for central poststroke pain. J Pain. 2004;5:192–4.

    PubMed  Google Scholar 

  74. Canavero S, Bonicalzi V, Paolotti R. Lack of effect of topiramate for central pain. Neurology. 2002;58:831–2.

    CAS  PubMed  Google Scholar 

  75. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389–400.

    CAS  PubMed  Google Scholar 

  76. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25:100–5.

    PubMed  Google Scholar 

  77. Serpell MG. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557–66.

    CAS  PubMed  Google Scholar 

  78. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004;63:2104–10.

    CAS  PubMed  Google Scholar 

  79. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628–38.

    CAS  PubMed  Google Scholar 

  80. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology. 2006;67:1792–800.

    CAS  PubMed  Google Scholar 

  81. Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152:1018–23.

    CAS  PubMed  Google Scholar 

  82. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573–81.

    PubMed  Google Scholar 

  83. Quessy SN, Rowbotham MC. Placebo response in neuropathic pain trials. Pain. 2008;138:479–83.

    PubMed  Google Scholar 

  84. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA. 1994;271:1609–14.

    CAS  PubMed  Google Scholar 

  85. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23:4315–23.

    CAS  PubMed  Google Scholar 

  86. Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D. Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology. 2002;58:554–63.

    CAS  PubMed  Google Scholar 

  87. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;348:1223–32.

    CAS  PubMed  Google Scholar 

  88. Bainton T, Fox M, Bowsher D, Wells C. A double-blind trial of naloxone in central post-stroke pain. Pain. 1992;48:159–62.

    CAS  PubMed  Google Scholar 

  89. Herman RM, D’Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain. 1992;8:338–45.

    CAS  PubMed  Google Scholar 

  90. Taira T, Tanikawa T, Kawamura H, Iseki H, Takakura K. Spinal intrathecal baclofen suppresses central pain after a stroke. J Neurol Neurosurg Psychiatry. 1994;57:381–2.

    CAS  PubMed Central  PubMed  Google Scholar 

  91. Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, Bouhassira D. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000;54:564–74.

    CAS  PubMed  Google Scholar 

  92. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery. 1995;37:1080–7.

    CAS  PubMed  Google Scholar 

  93. McQuay HJ, Carroll D, Jadad AR, Glynn CJ, Jack T, Moore RA, Wiffeh PJ. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain. 1994;59:127–33.

    CAS  PubMed  Google Scholar 

  94. Klotz U. Ziconotide—a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain—a short review. Int J Clin Pharmacol Ther. 2006;44:478–83.

    CAS  PubMed  Google Scholar 

  95. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or aids: a randomized controlled trial. JAMA. 2004;291:63–70.

    CAS  PubMed  Google Scholar 

  96. Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapata SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manag. 2006;31:393–406.

    CAS  Google Scholar 

  97. Wermeling DP, Berger JR. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy. 2006;26:395–402.

    PubMed  Google Scholar 

  98. Saulino M. Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report. Spinal Cord. 2007;45:749–52.

    CAS  PubMed  Google Scholar 

  99. Wallace MS, Rauck R, Fisher R, Charapata SG, Ellis D, Dissanayake S. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth Analg. 2008;106:628–37 table of contents.

    CAS  PubMed  Google Scholar 

  100. Tasker RR. Pain resulting from central nervous system pathology (central pain). Philadelphia.: Lea and Febiger; 1990.

    Google Scholar 

  101. Nashold BS Jr, Bullitt E. Dorsal root entry zone lesions to control central pain in paraplegics. J Neurosurg. 1981;55:414–9.

    PubMed  Google Scholar 

  102. Erickson TC, Bleckwenn WJ, Woolsey CN. Observations on the post central gyrus in relation to pain. Trans Am Neurol Assoc. 1952;56:57–9.

    CAS  PubMed  Google Scholar 

  103. Scarff JE. Unilateral prefrontal lobotomy for the relief of intractable pain. J Neurosurg. 1950;7:330–6.

    CAS  PubMed  Google Scholar 

  104. Luft R, Olivecrona H. Experiences with hypophysectomy in man. J Neurosurg. 1953;10:301–16.

    CAS  PubMed  Google Scholar 

  105. Backlund EO, Rahn T, Sarby B, De Schryver A, Wennerstrand J. Closed stereotaxic hypophysectomy by means of 60 Co gamma radiation. Acta Radiol Ther Phys Biol. 1972;11:545–55.

    CAS  PubMed  Google Scholar 

  106. Hayashi M, Chernov MF, Taira T, Ochiai T, Nakaya K, Tamura N, Goto S, Yomo S, Kouyama N, Katayama Y, Kawakami Y, Izawa M, Muragaki Y, Nakamura R, Iseki H, Hori T, Takakura K. Outcome after pituitary radiosurgery for thalamic pain syndrome. Int J Radiat Oncol Biol Phys. 2007;69:852–7.

    PubMed  Google Scholar 

  107. Leijon G, Boivie J. Central post-stroke pain–the effect of high and low frequency tens. Pain. 1989;38:187–91.

    CAS  PubMed  Google Scholar 

  108. Kumar K, Toth C, Nath RK. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery. 1997;40:736–46 discussion 746–737.

    CAS  PubMed  Google Scholar 

  109. Rasche D, Rinaldi PC, Young RF, Tronnier VM. Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus. 2006;21:E8.

    PubMed  Google Scholar 

  110. Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Chronic motor cortex stimulation in patients with thalamic pain. J Neurosurg. 1993;78:393–401.

    CAS  PubMed  Google Scholar 

  111. Lazorthes Y, Sol JC, Fowo S, Roux FE, Verdie JC. Motor cortex stimulation for neuropathic pain. Acta Neurochir Suppl. 2007;97:37–44.

    CAS  PubMed  Google Scholar 

  112. Saitoh Y, Yoshimine T. Stimulation of primary motor cortex for intractable deafferentation pain. Acta Neurochir Suppl. 2007;97:51–6.

    CAS  PubMed  Google Scholar 

  113. Saitoh Y, Hirayama A, Kishima H, Oshino S, Hirata M, Kato A, Yoshimine T. Stimulation of primary motor cortex for intractable deafferentation pain. Acta Neurochir Suppl. 2006;99:57–9.

    CAS  PubMed  Google Scholar 

  114. Lima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008;70:2329–37.

    PubMed  Google Scholar 

  115. Hosomi K, Shimokawa T, Ikoma K, Nakamura Y, Sugiyama K, Ugawa Y, Uozumi T, Yamamoto T, Saitoh Y. Daily repetitive transcranial magnetic stimulation of primary motor cortex for neuropathic pain: a randomized, multicenter, double-blind, crossover, sham-controlled trial. Pain. 2013;154:1065–72.

    PubMed  Google Scholar 

  116. O’Connell NE, Wand BM, Marston L, Spencer S, Desouza LH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2014;4:CD008208.

    PubMed  Google Scholar 

  117. Wetering EJ, Lemmens KM, Nieboer AP, Huijsman R. Cognitive and behavioral interventions for the management of chronic neuropathic pain in adults—a systematic review. Eur J Pain. 2010;14:670–81.

    PubMed  Google Scholar 

  118. Heutink M, Post MW, Bongers-Janssen HM, Dijkstra CA, Snoek GJ, Spijkerman DC, Lindeman E. The CONECSI trial: results of a randomized controlled trial of a multidisciplinary cognitive behavioral program for coping with chronic neuropathic pain after spinal cord injury. Pain. 2012;153:120–8.

    PubMed  Google Scholar 

  119. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374:1252–61.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to support the writing of this manuscript.

Conflict of interest

J.S. Kim has no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong S. Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, J.S. Pharmacological Management of Central Post-Stroke Pain: A Practical Guide. CNS Drugs 28, 787–797 (2014). https://doi.org/10.1007/s40263-014-0194-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40263-014-0194-y

Keywords

Navigation